Background: This is the only study to date of Triiodothyronine(T3) and Hydrocortisone (HC) in preterm infants. The pilot study will determine the dose of T3 in the multicentre trial examining the incidence of lung disease in preterm infants.

Subjects: Preterm infants less than 30 weeks gestation.

Log in or create a free account to read this content

Gain free access to this article, as well as selected content from this journal and more on nature.com

Access through your institution

or

Sign in or create an account
Continue with Google
Continue with ORCiD